From Breakingviews - Quiet quitting China will start with the Chinese
A worker in a protective suit looks out through a gap in barriers at a closed residential area during lockdown, amid the coronavirus disease pandemic, in Shanghai, China, May 25, 2022. REUTERS/Aly Song - RC27EU97RSMR
Western companies in the Middle Kingdom overwhelmingly rely on local suppliers, rather than running their own operations on the ground or dealing with other foreign firms. For example, a senior Tesla executive disclosed in August that its Shanghai factory was 95% supplied by domestic producers. Their prominence in the supply chain means local partners could offer Western groups a painless way out of their stay-or-go dilemma.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Breakingviews - China Covid ills go from bad to chronically worseProtests across China underscore a rising fear among people that President Xi Jinping’s stringent pandemic restrictions may be here to stay. Unfortunately, two squandered years to vaccinate vulnerable groups and bolster hospital resources validate those anxieties.
Read more »
China smartphone maker Xiaomi to slash 15% of jobs - South China Morning PostChina's Xiaomi Corp has started laying off workers in several units of its smartphone and internet services business, reducing its workforce by about 15%, the South China Morning Post reported on Tuesday.
Read more »
U.S. and China trade barbs over South China SeaChina's embassy in Manila accused the United States on Tuesday of driving a wedge between the Philippines and Beijing, deploring Washington's 'unfounded accusations' that it said sought to stir up trouble in the South China Sea.
Read more »
Breakingviews - Economic chaos will break Orbán’s strongman spiritCaught between a severe economic crisis, a restive population and his country’s need for foreign capital, Hungarian Prime Minister Viktor Orbán will spend 2023 trying to make friends with the European Union partners he scorned for years.
Read more »
Breakingviews - Big Pharma will find right formula for M&A bingeDrugmakers are primed for a shopping spree in 2023. Companies like Pfizer and GSK are in relatively rude health, thanks to bumper sales from vaccines and a post-pandemic recovery in cancer treatments. Chief executives have a potential half-trillion-dollar war chest to use on dealmaking. Their likely targets, listed biotechnology groups, are not in a position to play hardball.
Read more »
Breakingviews - Intrepid bankers will find Boutique Blvd jam-packedDeal advice has become a crowded trade. The situation complicates things for rainmakers considering their next steps in a weaker environment for mergers and acquisitions. Making the well-trod move from Wall Street to Boutique Boulevard will be much harder in 2023.
Read more »